Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.2B | 5.1B | 4.2B | 3.5B |
Cost of revenue | 2.2B | 3.5B | 2.9B | 2.4B |
Gross profit | 978.0M | 1.6B | 1.3B | 1.1B |
Operating expense | ||||
Research & development | 254.8M | 375.3M | 290.0M | 231.2M |
Selling general and admin | 251.6M | -147.7M | 525.1M | 8.5M |
Other operating expenses | 17.6M | 39.3M | 22.3M | 23.8M |
Operating income | 477.3M | 785.7M | 765.5M | 677.1M |
Non operating interest income | ||||
Income | 16.0M | 14.2M | 16.5M | 13.4M |
Expense | 1.9M | 5.1M | 1.6M | -738.5K |
Other income expense | — | — | — | — |
Pretax income | 514.3M | 687.8M | 690.7M | 638.8M |
Tax provision | 51.0M | 122.4M | 68.0M | 103.7M |
Net income | 463.4M | 565.5M | 622.7M | 535.1M |
Basic EPS | 0.6 | — | — | — |
Diluted EPS | 0.6 | — | — | — |
Basic average shares | 783.3M | — | — | — |
Diluted average shares | 783.3M | — | — | — |
EBITDA | 515.4M | 837.4M | 749.0M | 698.0M |
Net income from continuing op. | — | — | — | — |
Minority interests | -16.9M | -7.8M | -18.5M | -11.3M |
Preferred stock dividends | 0 | 0 | 0 | 0 |